Plexus Corp (NASDAQ: PLXS)

Plexus Corp designs, manufactures, and services highly complex products in demanding regulatory environments. The company operates in the electronics manufacturing services industry, catering to sectors such as Aerospace/Defense, Healthcare/Life Sciences, and Industrial. Plexus provides innovative solutions across the lifecycle of a product, from design and development to manufacturing and sustaining services. The company's global footprint includes 26 facilities across the Americas, Asia-Pacific, and Europe, Middle East and Africa regions, supporting a diverse customer base with over 20,000 team members.

Plexus generates revenue through a range of services and solutions that complement the entire product lifecycle. The company offers design and development services, supply chain solutions, new product introduction, manufacturing, and sustaining services. These services are provided on a turnkey basis, where Plexus procures and warehouses all materials required for product assembly, or on a consignment basis, where customers supply the necessary materials. Plexus does not design or manufacture its own proprietary products, focusing instead on providing comprehensive solutions to its customers. The company's primary products include advanced semiconductors, diodes, power management modules, microcontrollers, memory modules, interconnects, inductors, resistors, capacitors, power supplies, and cable and wire. Non-electronic components such as molded/formed plastics, sheet metal fabrications, aluminum extrusions, robotics, motors, vision sensors, motion/actuation, fluidics, displays, die castings, and various other hardware and fastener components are also sourced and integrated into the products.

• Aerospace/Defense: Plexus provides solutions for mission-critical aerospace and defense products. The company's capabilities include assembly of finished medical devices meeting U.S. Food and Drug Administration's Quality Systems Regulation requirements and similar regulatory requirements in other countries. Plexus also holds certifications such as ISO 13485:2016, 21 CFR Part 820 (FDA) (Finished Medical), JGMP accreditation, GMP-Korea certification, ANVISA accreditation, NPMA (National Medical Products Administration) registration, ISO 14001 (environmental management), ISO 45001 (occupational health and safety), ANSI/ESD (Electrostatic Discharge Control Program) S20.20, ITAR (International Traffic and Arms Regulation) self-declaration, Aerospace Standard AS9100, NADCAP certification, FAR 145 certification (FAA repair station), EASA repair approval, ATEX/IECEx certification, IRIS certification (Railway), ISO 50001:2011 (energy management), and Bureau of Indian Standards (BIS). These certifications and registrations cater to the stringent regulatory requirements of the aerospace and defense sector.

• Healthcare/Life Sciences: Plexus offers solutions for life-saving medical devices. The company's capabilities include assembly of finished medical devices meeting U.S. Food and Drug Administration's Quality Systems Regulation requirements and similar regulatory requirements in other countries. Plexus also holds certifications such as ISO 13485:2016, 21 CFR Part 820 (FDA) (Finished Medical), JGMP accreditation, GMP-Korea certification, ANVISA accreditation, NPMA (National Medical Products Administration) registration, ISO 14001 (environmental management), ISO 45001 (occupational health and safety), ANSI/ESD (Electrostatic Discharge Control Program) S20.20, ITAR (International Traffic and Arms Regulation) self-declaration, Aerospace Standard AS9100, NADCAP certification, FAR 145 certification (FAA repair station), EASA repair approval, ATEX/IECEx certification, IRIS certification (Railway), ISO 50001:2011 (energy management), and Bureau of Indian Standards (BIS). These certifications and registrations cater to the stringent regulatory requirements of the healthcare and life sciences sector.

• Industrial: Plexus provides solutions for industrial automation systems and semiconductor capital equipment. The company's capabilities include assembly of finished medical devices meeting U.S. Food and Drug Administration's Quality Systems Regulation requirements and similar regulatory requirements in other countries. Plexus also holds certifications such as ISO 13485:2016, 21 CFR Part 820 (FDA) (Finished Medical), JGMP accreditation, GMP-Korea certification, ANVISA accreditation, NPMA (National Medical Products Administration) registration, ISO 14001 (environmental management), ISO 45001 (occupational health and safety), ANSI/ESD (Electrostatic Discharge Control Program) S20.20, ITAR (International Traffic and Arms Regulation) self-declaration, Aerospace Standard AS9100, NADCAP certification, FAR 145 certification (FAA repair station), EASA repair approval, ATEX/IECEx certification, IRIS certification (Railway), ISO 50001:2011 (energy management), and Bureau of Indian Standards (BIS). These certifications and registrations cater to the stringent regulatory requirements of the industrial sector.

Plexus operates in a highly competitive market, with a goal to be best-in-class at meeting the unique needs of its customers. The company faces competition from various players, including those that provide services similar to Plexus, as well as more established competitors in certain industry sectors with greater financial, manufacturing, or marketing resources. Smaller competitors compete mainly in specific sectors and within limited geographic areas. Plexus also competes with in-house capabilities of current and potential customers. The company's ability to provide a full range of services that complement the entire product lifecycle across a global footprint provides a business advantage. Relative to its competition, Plexus invests more in inventory and selling and administrative costs due to lower manufacturing volumes, production flexibility, unique fulfillment requirements, and complex regulatory and quality requirements.

Plexus serves a diverse customer landscape that includes industry-leading, branded product companies, along with other technology pioneering start-ups and emerging companies that may or may not maintain manufacturing capabilities. During fiscal 2025, the company served approximately 190 customers. No customer accounted for over 10% of its sales in fiscal 2025 or 2024. Many of its large customers contract with Plexus through multiple independent divisions, subsidiaries, production facilities, or locations. The company believes that in most cases its sales to any one such division, subsidiary, facility, or location are independent of sales to others.